In 2025, Galderma Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Galderma Group has also provided a category-level breakdown for 7 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 11,170.6a | 8,496.9a | 7,600b | |
Total Scope 2 | ||||
Market-Based | 396.7a | 322.5a | 700c | |
Location-Based | 5,616.6a | 5,322.1a | 5,500c | |
Total Scope 3 | 467,097.9a | 284,830.4a | 332,100b | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 2.1314a | 1.9137a | 1.846b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Galderma Group amounted to 16,787.2 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Galderma Group increased by 21.48%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Galderma Group were 11,170.6 metric tons of CO₂ equivalent (tCO₂e).a
Since 2022, Galderma Group's Scope 1 emissions have increased by 13.99%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year (2024), Galderma Group's Scope 1 emissions increased by 31.47%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Galderma Group reported Scope 2 greenhouse gas (GHG) emissions of 396.7 tCO₂e using the market-based method and 5,616.6 tCO₂e using the location-based method.a
Since 2022, Galderma Group's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have remained relatively stable, indicating that Galderma Group's emissions have plateaued with no significant change in its energy consumption footprint.ac
Compared to the previous year (2024), Galderma Group's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Galderma Group's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Galderma Group reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Galderma Group reported 467,097.9 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Galderma Group includes a breakdown across 7 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Galderma Group reported total Scope 3 emissions of 467,097.9 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2024), Galderma Group's Scope 3 emissions increased by 63.99%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2025, Galderma Group reported emissions for 7 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Galderma Group's Scope 3 emissions were:a
In 2025, Galderma Group reported Scope 1 greenhouse gas (GHG) emissions of 11,170.6 tCO₂e and total revenues of USD 5,241 millions. This translates into an emissions intensity of 2.13 tCO₂e per millions USD.a
In 2025, Galderma Group reported a Scope 1 emissions intensity of 2.13 tCO₂e per millions USD. Compared to the peer group median of 13.95, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Galderma Group ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Galderma Group among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2025, Galderma Group reported a total carbon footprint of 483,885.1 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 62.02% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Galderma Group's total carbon footprint was Scope 3 emissions, accounting for 96.53% of the company's total carbon footprint, followed by Scope 1 emissions at 2.31%.a